Healthcare -
Biotechnology - NYSE - US
$ 1.75
-4.37 %
$ 34.1 M
Market Cap
-0.41
P/E
ANVS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ANVS - Annovis Bio, Inc.
17.3 M
LAST VALUE
-39.09%
2 YEAR CAGR
134.15%
5 YEAR CAGR
0.00%
10 YEAR CAGR